Discover
NGNE
Neurogene Inc.
27.55
2 x 25.99
2 x 44.63
bid
ask
-
1.27
4.41%
2 @ 04:00 PM
28.10 +0.55 (2.00%)
| Ytd | 33.74% | |
| 1y | -16.87% |
26.77
day range
29.38
15.93
52 week range
43.66
| Open | 28.53 | Prev Close | 28.82 | Low | 26.77 | High | 29.38 | Mkt Cap | 551.31M |
| Vol | 249.04K | Avg Vol | 291.89K | EPS | -5.04 | P/E | N/A | Forward P/E | -4.85 |
| Beta | N/A | Short Ratio | 7.15 | Inst. Own | 110.72% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 30.94 | 200-d Avg | 27.77 | 1yr Est | 52.80 |
| Income Statement | |||
| Operating Expenses | 36.67M | ||
| Research and Development Expense | 25.47M | ||
| Selling, General and Administrative Expense | 11.20M | ||
| Operating Income | -36.67M | ||
| Net Income | -34.49M | ||
| Net Income Common Stock | -34.49M | ||
| Net Income Common Stock (USD) | -34.49M | ||
| Consolidated Income | -34.49M | ||
| Earnings per Basic Share | -1.53 | ||
| Earnings per Basic Share (USD) | -1.53 | ||
| Earnings per Diluted Share | -1.53 | ||
| Earning Before Interest & Taxes (EBIT) | -34.49M | ||
| Earning Before Interest & Taxes (USD) | -34.49M | ||
| Weighted Average Shares | 22.55M | ||
| Weighted Average Shares Diluted | 22.55M | ||
| Balance Sheet | |||
| Cash and Equivalents | 112.82M | ||
| Cash and Equivalents (USD) | 112.82M | ||
| Investments | 112.91M | ||
| Investments Current | 112.91M | ||
| Current Assets | 228.91M | ||
| Property, Plant & Equipment Net | 14.01M | ||
| Total Assets | 244.36M | ||
| Debt Current | 3.03M | ||
| Total Debt | 8.35M | ||
| Current Liabilities | 21.51M | ||
| Debt Non-Current | 5.32M | ||
| Total Liabilities | 27.23M | ||
| Accumulated Retained Earnings (Deficit) | -418.07M | ||
| Shareholders Equity | 217.13M | ||
| Shareholders Equity (USD) | 217.13M | ||
| Assets Non-Current | 15.45M | ||
| Total Debt (USD) | 8.35M | ||
| Liabilities Non-Current | 5.73M | ||
| Trade and Non-Trade Payables | 3.29M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.01M | ||
| Net Cash Flow from Financing | 5.98M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -11.68M | ||
| Capital Expenditure | -354.00K | ||
| Issuance (Purchase) of Equity Shares | 6.00M | ||
| Issuance (Repayment) of Debt Securities | -5.00K | ||
| Net Cash Flow from Investing | 6.10M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 6.46M | ||
| Net Cash Flow from Operations | -23.76M | ||
| Share Based Compensation | 7.86M | ||